Literature DB >> 8189763

Cutaneous laser Doppler flowmetry: applications and findings.

A M Schabauer1, T W Rooke.   

Abstract

OBJECTIVE: To examine the historical development, evolution, strengths and weaknesses, and applications (current and future) of laser Doppler flowmetry (LDF).
DESIGN: A review and summary of the literature on the cutaneous uses and successful applications of LDF are presented as well as a brief discussion of the noncutaneous and nonvascular applications.
MATERIAL AND METHODS: LDF measures Doppler-shifted quantities of reflected laser light at a superficial level to determine cutaneous and noncutaneous microcirculatory flux of erythrocytes. LDF is non-invasive and inexpensive.
RESULTS: This relatively recent technologic development has shown considerable potential as a tool for evaluating the cutaneous circulation. Although early studies suggested that LDF had substantial difficulties with sampling, stability, and reproducibility, subsequent refinements in equipment and application have led to technical acceptability.
CONCLUSION: LDF seems to be particularly valuable for assessing the microcirculation and real-time changes in skin blood flow. It has been used successfully in many investigations of the cutaneous and noncutaneous blood flow in patients with fixed or vasospastic vascular disorders, neuropathies, tumors, or ulcers as well as those who have undergone intestinal, orthopedic, or plastic surgical procedures.

Entities:  

Mesh:

Year:  1994        PMID: 8189763     DOI: 10.1016/s0025-6196(12)62249-6

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  19 in total

1.  Validation of laser Doppler flowmetry coupled with intra-dermal injection for investigating effects of vasoactive agents on the skin microcirculation in man.

Authors:  Stephen J Leslie; Jonathan Affolter; Martin A Denvir; David J Webb
Journal:  Eur J Clin Pharmacol       Date:  2003-04-30       Impact factor: 2.953

Review 2.  Noninvasive monitoring of peripheral perfusion.

Authors:  Alexandre Lima; Jan Bakker
Journal:  Intensive Care Med       Date:  2005-09-17       Impact factor: 17.440

Review 3.  Quantifying digital vascular disease in patients with primary Raynaud's phenomenon and systemic sclerosis.

Authors:  A L Herrick; S Clark
Journal:  Ann Rheum Dis       Date:  1998-02       Impact factor: 19.103

Review 4.  Synovial perfusion and synovial fluid solutes.

Authors:  P A Simkin
Journal:  Ann Rheum Dis       Date:  1995-05       Impact factor: 19.103

5.  Laser Doppler measurement of rectal mucosal blood flow.

Authors:  A V Emmanuel; M A Kamm
Journal:  Gut       Date:  1999-07       Impact factor: 23.059

6.  Facilitating laser Doppler measurements of cutaneous adrenergic vasoconstriction: a comparison of methods.

Authors:  D M Lipnicki; P D Drummond
Journal:  Clin Auton Res       Date:  2001-04       Impact factor: 4.435

7.  Aged garlic extract preserves cutaneous microcirculation in patients with increased risk for cardiovascular diseases: A double-blinded placebo-controlled study.

Authors:  Martine Wlosinska; Ann-Christin Nilsson; Joanna Hlebowicz; Malin Malmsjö; Mohammed Fakhro; Sandra Lindstedt
Journal:  Int Wound J       Date:  2019-09-13       Impact factor: 3.315

8.  Measuring niacin-associated skin toxicity (NASTy) stigmata along with symptoms to aid development of niacin mimetics.

Authors:  Richard L Dunbar; Harsh Goel; Sony Tuteja; Wen-Liang Song; Grace Nathanson; Zeeshan Babar; Dusanka Lalic; Joel M Gelfand; Daniel J Rader; Gary L Grove
Journal:  J Lipid Res       Date:  2017-01-23       Impact factor: 5.922

9.  Reproducibility of the capsaicin-induced dermal blood flow response as assessed by laser Doppler perfusion imaging.

Authors:  B J Van der Schueren; J N de Hoon; F H Vanmolkot; A Van Hecken; M Depre; S A Kane; I De Lepeleire; S R Sinclair
Journal:  Br J Clin Pharmacol       Date:  2007-06-19       Impact factor: 4.335

10.  Ocular blood flow alteration in glaucoma is related to systemic vascular dysregulation.

Authors:  M Emre; S Orgül; K Gugleta; J Flammer
Journal:  Br J Ophthalmol       Date:  2004-05       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.